Skip to main content

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia. This has thereby become the first plant anywhere in the world to produce sustainable rhamnolipid biosurfactants.

Slovenská Lupca produces rhamnolipids via a proprietary fermentation process that uses European corn sugar as the main raw material. They are fully biodegradable, with a low toxicological and ecotoxicological profile, as well as being entirely biobased.

Evonik plans ultra-pure colloidal silica plant

Evonik has revealed that it is building a $7.9 million plant to produce ultra-high purity colloidal silica at its site in Weston, Michigan. Due onstream in 2024, this will be the first of its kind in North America. The investment was supported by a $900,000 performance-based grant under the Michigan Business Development Programme.

Evonik targets €1 billion+ in circular economy sales

Evonik has revealed that it aims to generate at least €1 billion/year in additional sales a year from circular products and technologies, both in its own processes and support its customers in the transition to circular applications. The company’s strategy in this arena is based on multiple initiatives in which it claims that it is already contributing to the circular economy, notably:

* Further strengthening its activities in additives and specialities for the circular economy

* Making greater use of raw materials based on recycled materials, biomass and CO2

Evonik completes catalyst powder expansion

Evonik has completed the relocation and expansion of its precious metal powder catalyst plant in Shanghai Chemical Industrial Park. Production is scheduled to commence in Q4. No financial details were disclosed.

This completes the upgrade of the company’s global network of five precious metal catalyst plants. Evonik sells the catalysts under the Noblyst P brand name mainly for applications in APIs and agrochemical AIs. China is one of the fastest-growing markets for them.

SBTi validates Evonik climate targets

The independent Science-Based Targets Initiative (SBTi) has confirmed that Evonik’s greenhouse gas emission reduction targets are in line with the Paris Agreement on Climate Change. This seeks to limit global warming to well below 2°C.

Heraeus, Evonik collaborate on HPAPIs

Germany-based Evonik and Heraeus Precious Metals have announced that they are collaborating to expand their range of services for HPAPIs. They intend to build a fully integrated offering from the pre-clinical stage to commercial manufacturing, with streamlined transfer between small- and large-scale production between their respective sites.

Heraeus’s Pharmaceutical Ingredients business offers customised services for both earlier and later clinical phases and smaller to mid-volume HPAPI commercial products. It claims to be the world’s leading supplier of platinum-based HPAPIs.

Evonik acquires Argentine firm

Subject only to official approval, Evonik has acquired Novachem, a maker of biotechnological, natural and sustainable actives for skin and hair care applications based in Buenos Aires. Novachem will be integrated into the Care Solutions business line within the Nutrition & Care division.

Subscribe to Evonik